Longtime CVS Health executive David Joyner has replaced Karen Lynch as CEO, as the company struggles to drive higher profits and stock performance, CVS announced Friday. CVS has faced challenges as higher medical costs weigh on its insurance unit, Aetna, and consumer spending drops at its retail pharmacies. It anticipates higher medical costs than previously expected, with a so-called medical benefit ratio of 95.2% in the quarter. CNBC reported last month that CVS’ board had engaged strategic advisors to weigh its options, including the potential of a breakup of its insurance and retail businesses. Lynch also stepped down from the company’s board of directors this week, the company said Friday.

---

Persons: David Joyner, Karen Lynch, CVS, ” CVS, Joyner, Lynch, “, David, Roger Farah, Farah Organizations: CVS, Aetna, Glenview Capital, CNBC, CVS Health